paliperidone
paliperidone is a pharmaceutical drug with 37 clinical trials. Currently 1 active trials ongoing. Historical success rate of 87.1%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
5
Mid Stage
22
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
79.4%
27 of 34 finished
20.6%
7 ended early
1
trials recruiting
37
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
"Extended" (Alternate Day) Antipsychotic Dosing
Substance Misuse To Psychosis for Stimulants
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Clinical Trials (37)
"Extended" (Alternate Day) Antipsychotic Dosing
Substance Misuse To Psychosis for Stimulants
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
European Long-acting Antipsychotics in Schizophrenia Trial
A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Pharmacovigilance in Gerontopsychiatric Patients
Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia
An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 37